Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonal M Manohar

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Future Medicinal Chemistry|July 26, 2022
The story of EGFR: from signaling pathways to a potent anticancer targetSaloni Ramani, Sayalee Samant, Sonal M Manohar
Current Issues in Molecular Biology|September 29, 2025
Combination of the First-in-Class Imipridone ONC201 and Standard Anticancer Therapies as a Rational Approach for Therapeutic BenefitBrahmi Shenoy, Miloni Mandani, Meena Chintamaneni, et al.
Molecular Cancer|October 19, 2012
P276-00, a cyclin-dependent kinase inhibitor, modulates cell cycle and induces apoptosis in vitro and in vivo in mantle cell lymphoma cell linesNitesh P Shirsath, Sonal M Manohar, Kalpana S Joshi
Journal of Translational Medicine|August 10, 2012
Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancersMaggie J Rathos, Kavita Joshi, Harshal Khanwalkar, et al.
BMC Cancer|January 25, 2013
Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cellsMaggie J Rathos, Harshal Khanwalkar, Kavita Joshi, et al.
Biochemical and Biophysical Research Communications|November 25, 2025
Flow Cytometry: a versatile tool for stem cell researchSonal M Manohar, Shriya Chaubal, Srabani Mukherjee, et al.
Leukemia Research|January 11, 2011
Cyclin-dependent kinase inhibitor, P276-00 induces apoptosis in multiple myeloma cells by inhibition of Cdk9-T1 and RNA polymerase II-dependent transcriptionSonal M Manohar, Maggie J Rathos, Vinay Sonawane, et al.
BMC Cancer|August 9, 2011
A novel inhibitor of hypoxia-inducible factor-1α P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cellsSonal M Manohar, Amol A Padgaonkar, Archana Jalota-Badhwar, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Future Medicinal Chemistry|July 26, 2022
The story of EGFR: from signaling pathways to a potent anticancer targetSaloni Ramani, Sayalee Samant, Sonal M Manohar
Current Issues in Molecular Biology|September 29, 2025
Combination of the First-in-Class Imipridone ONC201 and Standard Anticancer Therapies as a Rational Approach for Therapeutic BenefitBrahmi Shenoy, Miloni Mandani, Meena Chintamaneni, et al.
Molecular Cancer|October 19, 2012
P276-00, a cyclin-dependent kinase inhibitor, modulates cell cycle and induces apoptosis in vitro and in vivo in mantle cell lymphoma cell linesNitesh P Shirsath, Sonal M Manohar, Kalpana S Joshi
Journal of Translational Medicine|August 10, 2012
Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancersMaggie J Rathos, Kavita Joshi, Harshal Khanwalkar, et al.
BMC Cancer|January 25, 2013
Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cellsMaggie J Rathos, Harshal Khanwalkar, Kavita Joshi, et al.
Biochemical and Biophysical Research Communications|November 25, 2025
Flow Cytometry: a versatile tool for stem cell researchSonal M Manohar, Shriya Chaubal, Srabani Mukherjee, et al.
Leukemia Research|January 11, 2011
Cyclin-dependent kinase inhibitor, P276-00 induces apoptosis in multiple myeloma cells by inhibition of Cdk9-T1 and RNA polymerase II-dependent transcriptionSonal M Manohar, Maggie J Rathos, Vinay Sonawane, et al.
BMC Cancer|August 9, 2011
A novel inhibitor of hypoxia-inducible factor-1α P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cellsSonal M Manohar, Amol A Padgaonkar, Archana Jalota-Badhwar, et al.
Pageof 2